NYSE:PBHPrestige Consumer Healthcare Stock Price, Forecast & News

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PBH stock has increased by 3.4% and is now trading at $37.12. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Prestige Consumer Healthcare.

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Prestige Consumer Healthcare.

Prestige Consumer Healthcare will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Prestige Consumer Healthcare Inc (NYSE:PBH) released its quarterly earnings data on Thursday, May, 7th. The company reported $0.82 EPS for the quarter, topping the consensus estimate of $0.74 by $0.08. The firm earned $251.20 million during the quarter, compared to analysts' expectations of $239.65 million. Prestige Consumer Healthcare had a return on equity of 13.33% and a net margin of 14.77%. The firm's quarterly revenue was up 4.2% on a year-over-year basis. During the same period last year, the company earned $0.72 earnings per share. View Prestige Consumer Healthcare's earnings history.

Prestige Consumer Healthcare issued an update on its first quarter earnings guidance on Thursday, May, 7th. The company provided EPS guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.69. The company issued revenue guidance of ~$220 million or more, compared to the consensus revenue estimate of $232.21 million.

7 equities research analysts have issued twelve-month price targets for Prestige Consumer Healthcare's stock. Their forecasts range from $43.00 to $91.00. On average, they anticipate Prestige Consumer Healthcare's share price to reach $66.83 in the next year. This suggests a possible upside of 80.0% from the stock's current price. View analysts' price targets for Prestige Consumer Healthcare.

News stories about PBH stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Prestige Consumer Healthcare earned a daily sentiment score of 1.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Prestige Consumer Healthcare.

Prestige Consumer Healthcare saw a increase in short interest in June. As of June 30th, there was short interest totaling 4,880,000 shares, an increase of 22.6% from the June 15th total of 3,980,000 shares. Based on an average daily trading volume, of 476,100 shares, the days-to-cover ratio is presently 10.2 days. Currently, 9.8% of the shares of the stock are sold short. View Prestige Consumer Healthcare's Current Options Chain.

Some companies that are related to Prestige Consumer Healthcare include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV), Veru (VERU) and Nature's Sunshine Products (NATR). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Gilead Sciences (GILD), AbbVie (ABBV), GW Pharmaceuticals PLC- (GWPH), Johnson & Johnson (JNJ), TG Therapeutics (TGTX), Flexion Therapeutics (FLXN), Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T) and Thermo Fisher Scientific (TMO).

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Prestige Consumer Healthcare's stock is owned by a number of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.60%), Wedge Capital Management L L P NC (0.55%), Skyline Asset Management LP (0.18%), Envestnet Asset Management Inc. (0.05%), Diversified Trust Co (0.03%) and Louisiana State Employees Retirement System (0.02%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors. View institutional ownership trends for Prestige Consumer Healthcare.

PBH stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., and Skyline Asset Management LP. View insider buying and selling activity for Prestige Consumer Healthcare.

PBH stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Contravisory Investment Management Inc., Envestnet Asset Management Inc., Diversified Trust Co, and Louisiana State Employees Retirement System. View insider buying and selling activity for Prestige Consumer Healthcare.

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PBH stock can currently be purchased for approximately $37.12.

Prestige Consumer Healthcare has a market capitalization of $1.86 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]